Skip to content

Clinical trials

Phase 2/3 Lymphoma, Large B-Cell, Diffuse trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Phase: Phase 2/3 Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20102
20131
20163
20171
20191
20201
20211
20221
20231
20241
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Unknown status4
Active, not recruiting3
Recruiting3
Terminated3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)2
Celgene1
Dizal Pharmaceuticals1
European Organisation for Research and Treatment of Cancer - EORTC1
Fondazione Italiana Linfomi - ETS1
Gilead Sciences1
Health Institutes of Turkey1
Incyte Corporation1
Karyopharm Therapeutics Inc1
Lymphoma Study Association1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse20
Lymphoma, Non-Hodgkin6
Lymphoma4
Lymphoma, B-Cell, Marginal Zone4
Lymphoma, Follicular4
Burkitt Lymphoma3
Leukemia, Lymphocytic, Chronic, B-Cell3
Lymphoma, Mantle-Cell3
Recurrence3
Lymphoma, Large-Cell, Immunoblastic2

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.